Intellectual Property India Publishes Patent Application for Substituted Heterocyclic Compounds And Their Derivatives As Cbp And/Or P300 Degraders

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647127885 A) filed by Aurigene Oncology Limited on October 27, 2026, for Substituted Heterocyclic Compounds And Their Derivatives As Cbp And/Or P300 Degraders.

Inventors include Abbineni, Chandrasekhar; Samajdar, Susanta; and Talluri, Krishna Chaitanya.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present disclosure provides substituted heterocyclic compounds of formula (I) or a pharmaceutically acceptable salt thereof or a stereoisomer thereof, which are therapeutically useful as CBP and/or p300 degraders. These compounds are useful in the treatment and/or prevention of diseases and/or d...